| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +23% |
| 3Y CAGR | +11% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +257% |
| 3Y CAGR | +77% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,754.70 -54.00 (1.42%) | 17,417.08 | 23.69 | 4.14 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,221.60 -37.20 (1.65%) | 17,194.23 | 25.36 | 5.1 | ||
Natco PharmaNATCOPHARM | ₹784.45 -16.40 (2.05%) | 15,708.15 | 13.72 | 1.5 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,079.50 +40.00 (0.66%) | 15,108.25 | 89.07 | 17.31 |